Fact CheckerSign in

NCT07289685Completed

Use a Wearable Devices to Observe Complications of Mobilization for Colorectal Cancer After Surgery

Source: ClinicalTrials.gov · Last updated 17 Dec 2025

Brief summary (registry, in English)

This study aims to help patients recover faster after colorectal cancer surgery by using wearable devices to monitor early movement. Patients will wear a lightweight wristband that tracks heart rate, sleep, and daily steps after surgery. The goal is to find out if early walking can reduce the chances of complications, shorten hospital stays, and lower medical costs. Participants will start wearing the device after surgery and continue for about 7 days or until they leave the hospital. During this time, they will also fill out a simple daily observation form. Participation is voluntary, and patients can withdraw at any time without affecting their care. The study hopes to provide new ways to improve recovery and offer better support to patients after colorectal surgery.

Status (registry)
Completed
Study type
Observational
Enrollment
192 (actual)
First submitted
20 Aug 2025
Start date
Aug 2022
Primary completion date
Jan 2024
Lead sponsor
Chang Gung Memorial Hospital
NCT number
NCT07289685

What you commit to

  • Study type: Observational
  • Participants enrolled: 192
  • From Aug 2022 to the primary completion date, Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients undergoing traditional open or local resection surgeries.

Other illness

  • Patients with acute/chronic psychiatric disorders or cognitive impairment.

Who the study is looking for

  • Patients undergoing minimally invasive colorectal tumor resection.
  • Aged 20 to 85 years.
  • ECOG score 0-2.
  • Clear consciousness and ability to communicate in Mandarin or Taiwanese (or via family translation).
  • Informed consent provided by the patient or family.

Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Chang Gung Memorial Hospital, Linkou
Coordinator of this site? Confirm its status
TaoyuanTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.